PPR and Goatpox immunization programs expected from February 2026
Government immunization programs for PPR and goatpox (LSD) are expected to commence from February 2026, improving animal health division momentum in Q4.
HESTERBIO / guidance tracker
Keep management guidance in view.
Hester Biosciences · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Remaining CWIP to be capitalized over coming months
The remaining capital work in progress (₹182 Cr) is expected to be capitalized in the coming months, adding capacity.
Year-on-year margin improvement assured
Management assured year-on-year improvement in margins, though quarterly margins may vary due to product mix seasonality.
Animal healthcare recovery from Q1 FY27
Management expects animal healthcare division to recover from Q1 FY27 after tender delays in FY26.
Target 50:50 revenue mix between poultry and animal health
Management aims to achieve a balanced revenue mix of 50% poultry and 50% animal health over time.
Sustain poultry quarterly revenue of ~₹65 crore with 30% margins
Management aims to sustain the Q4 poultry revenue run-rate of ~₹65 crore and EBITDA margins around 30%.